Bristol Myers Squibb and Repertoire Announce $1.8B Deal to Reset Immune System in Autoimmune Patients
Repertoire Immune Medicines, a biotechnology company pioneering the discovery and development of programmable T cell targeted immune medicines, announced today that it has entered a multi-year strateg
Express News | Bristol-Myers Squibb Co - Under Terms of Agreement, Repertoire Will Receive up to $1.8 Bln for Achieving Development, Regulatory Commercial Milestones
Express News | Bristol-Myers Squibb Co - Under Terms of Agreement, Repertoire Will Receive an Upfront Payment of $65 Mln
Express News | Repertoire® Immune Medicines and Bristol Myers Squibb Announce Multi-Year Strategic Collaboration to Develop Tolerizing Vaccines for Autoimmune Diseases
Apple Might Be Able to Phone It In Now -- Heard on the Street -- WSJ
By Dan Gallagher Apple's biggest business is struggling. The fact that investors are finally wrapping their arms around that idea could turn out to be a good thing for the company ahead of its expect
Visa Insider Sold Shares Worth $250,472, According to a Recent SEC Filing
Lloyd Carney, Director, on April 26, 2024, sold 909 shares in Visa (V) for $250,472. Following the Form 4 filing with the SEC, Carney has control over a total of 2,591 shares of the company, with 2,59
HopelessChi : hence chinese equity market is still weak and lack of confidence. profit taking been for the past 18 days. another lower high at 4,800, guess back to stoneage time. exit while you can